{
  "id": 20302653,
  "title": "J&J bets $2.2B on Ollin’s vision loss drug",
  "url": "https://urgent.news/2026/11/16/j-j-bets-2-2b-on-ollins-vision-loss-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T16:57:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/Johnson-johnson-ollin-acquire-ophthalmology-vegf-ang2-drugs/874728/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The deal hands J&J a treatment that could complement its existing eye care franchise, but would vie for share of a crowded and competitive market.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}